Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emma C Morris

Showing results (31-40 of 77) with videos related to

Pageof 8
Sort By:
Frontiers in Immunology|December 15, 2025
The T385M STAT1 gain-of-function mutation confers the most severe disease outcomesRobert Torrance, Alexander J McKenna, Catherine King, et al.
Journal of Clinical Immunology|June 20, 2022
Quality of Life and Social and Psychological Outcomes in Adulthood Following Allogeneic HSCT in Childhood for Inborn Errors of ImmunityBethany Nicholson, Rupert Goodman, James Day, et al.
Transplantation and Cellular Therapy|May 7, 2021
Natural History of Epstein-Barr Virus Replication and Viral Load Dynamics after Alemtuzumab-Based Allogeneic Stem Cell TransplantationMaria A V Marzolini, Andrew J Wilson, Emilie Sanchez, et al.
Blood|March 31, 2011
Specificity for the tumor-associated self-antigen WT1 drives the development of fully functional memory T cells in the absence of vaccinationConstandina Pospori, Shao-An Xue, Angelika Holler, et al.
Journal of Clinical Immunology|March 17, 2023
Non-osteopenic Bone Pathology After Allo-hematopoietic Stem Cell Transplantation in Patients with Inborn Errors of ImmunityZainab M Golwala, Nikita Gireesh Bhat, Jinhua Xu-Bayford, et al.
Clinical and Experimental Immunology|February 1, 2023
Practical challenges for functional validation of STAT1 gain of function genetic variantsAdriana S Albuquerque, Jesmeen Maimaris, Alexander J McKenna, et al.
British Journal of Haematology|June 30, 2015
Autologous stem cell transplantation outcomes in elderly patients with B cell Non-Hodgkin LymphomaSatyen H Gohil, Kirit M Ardeshna, Jonathan M Lambert, et al.
The Biochemical Journal|December 10, 2002
Murine serpin 2A is a redox-sensitive intracellular proteinEmma C Morris, Timothy R Dafforn, Sharon L Forsyth, et al.
Oncoimmunology|March 14, 2013
Human MHC Class I-restricted high avidity CD4<sup>+</sup> T cells generated by co-transfer of TCR and CD8 mediate efficient tumor rejection in vivoShao-An Xue, Liquan Gao, Maryam Ahmadi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2008
Favorable long-term survival after reduced-intensity allogeneic transplantation for multiple-relapse aggressive non-Hodgkin's lymphomaKirsty J Thomson, Emma C Morris, Adrian Bloor, et al.
Pageof 8

Showing results (31-40 of 77) with videos related to

Sort By:
Pageof 8
Frontiers in Immunology|December 15, 2025
The T385M STAT1 gain-of-function mutation confers the most severe disease outcomesRobert Torrance, Alexander J McKenna, Catherine King, et al.
Journal of Clinical Immunology|June 20, 2022
Quality of Life and Social and Psychological Outcomes in Adulthood Following Allogeneic HSCT in Childhood for Inborn Errors of ImmunityBethany Nicholson, Rupert Goodman, James Day, et al.
Transplantation and Cellular Therapy|May 7, 2021
Natural History of Epstein-Barr Virus Replication and Viral Load Dynamics after Alemtuzumab-Based Allogeneic Stem Cell TransplantationMaria A V Marzolini, Andrew J Wilson, Emilie Sanchez, et al.
Blood|March 31, 2011
Specificity for the tumor-associated self-antigen WT1 drives the development of fully functional memory T cells in the absence of vaccinationConstandina Pospori, Shao-An Xue, Angelika Holler, et al.
Journal of Clinical Immunology|March 17, 2023
Non-osteopenic Bone Pathology After Allo-hematopoietic Stem Cell Transplantation in Patients with Inborn Errors of ImmunityZainab M Golwala, Nikita Gireesh Bhat, Jinhua Xu-Bayford, et al.
Clinical and Experimental Immunology|February 1, 2023
Practical challenges for functional validation of STAT1 gain of function genetic variantsAdriana S Albuquerque, Jesmeen Maimaris, Alexander J McKenna, et al.
British Journal of Haematology|June 30, 2015
Autologous stem cell transplantation outcomes in elderly patients with B cell Non-Hodgkin LymphomaSatyen H Gohil, Kirit M Ardeshna, Jonathan M Lambert, et al.
The Biochemical Journal|December 10, 2002
Murine serpin 2A is a redox-sensitive intracellular proteinEmma C Morris, Timothy R Dafforn, Sharon L Forsyth, et al.
Oncoimmunology|March 14, 2013
Human MHC Class I-restricted high avidity CD4<sup>+</sup> T cells generated by co-transfer of TCR and CD8 mediate efficient tumor rejection in vivoShao-An Xue, Liquan Gao, Maryam Ahmadi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2008
Favorable long-term survival after reduced-intensity allogeneic transplantation for multiple-relapse aggressive non-Hodgkin's lymphomaKirsty J Thomson, Emma C Morris, Adrian Bloor, et al.
Pageof 8